Center for Cancer and Blood Disorders — Washington D.C., District of Columbia

Center for Cancer and Blood Disorders is a clinical research site located in Washington D.C., District of Columbia, United States 20010-2970.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Center for Cancer and Blood Disorders has participated in 1 clinical trials.

Therapeutic areas: Sickle Cell Disease, Iron Overload, Hemolytic Anemia.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Center for Cancer and Blood Disorders?

Center for Cancer and Blood Disorders has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Center for Cancer and Blood Disorders conducted?

Center for Cancer and Blood Disorders has 1 clinical trials on record. Their work covers Sickle Cell Disease, Iron Overload, Hemolytic Anemia.

Is Center for Cancer and Blood Disorders accredited by Crixeo Health?

Center for Cancer and Blood Disorders has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Center for Cancer and Blood Disorders?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.